IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,194,139 | -50.5% | 26,974 | -54.1% | 0.03% | -46.9% |
| Q2 2023 | $2,410,512 | +11.9% | 58,750 | -2.5% | 0.05% | +8.9% |
| Q1 2023 | $2,153,728 | +309.5% | 60,261 | +414.6% | 0.04% | +350.0% |
| Q1 2021 | $526,000 | +20.9% | 11,710 | +52.4% | 0.01% | +25.0% |
| Q4 2020 | $435,000 | -24.9% | 7,685 | -37.0% | 0.01% | -38.5% |
| Q3 2020 | $579,000 | -30.0% | 12,206 | -12.9% | 0.01% | -31.6% |
| Q2 2020 | $827,000 | -11.3% | 14,019 | -28.9% | 0.02% | -29.6% |
| Q1 2020 | $932,000 | -31.5% | 19,718 | -12.4% | 0.03% | -12.9% |
| Q4 2019 | $1,360,000 | -10.5% | 22,499 | -11.3% | 0.03% | -16.2% |
| Q3 2019 | $1,519,000 | – | 25,363 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |